Cite
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts
MLA
Arik Bernard Schulze, et al. “High Expression of Transcription Factor POU2F1 Confers Improved Survival on Smokers with Lung Adenocarcinoma: A Retrospective Study of Two Cohorts.” Translational Lung Cancer Research, vol. 12, Apr. 2023, pp. 727–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9af5d2355d43a48f9a13487dfe85f463&authtype=sso&custid=ns315887.
APA
Arik Bernard Schulze, Daniela Vanessa Wenge, Georg Evers, Birthe Heitkötter, Annalen Bleckmann, Lars Henning Schmidt, Michael Mohr, Wolfgang Hartmann, Maria Francisca Arteaga, & Jan-Henrik Mikesch. (2023). High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts. Translational Lung Cancer Research, 12, 727–741.
Chicago
Arik Bernard Schulze, Daniela Vanessa Wenge, Georg Evers, Birthe Heitkötter, Annalen Bleckmann, Lars Henning Schmidt, Michael Mohr, Wolfgang Hartmann, Maria Francisca Arteaga, and Jan-Henrik Mikesch. 2023. “High Expression of Transcription Factor POU2F1 Confers Improved Survival on Smokers with Lung Adenocarcinoma: A Retrospective Study of Two Cohorts.” Translational Lung Cancer Research 12 (April): 727–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9af5d2355d43a48f9a13487dfe85f463&authtype=sso&custid=ns315887.